Charles A. Herzog, MD, FACC, FAHA
Charles A. Herzog, MD, FACC, FAHA, is Director of the Cardiovascular Special Studies Center, United States Renal Data System (USRDS). An investigator at the USRDS since 1999, Dr. Herzog has been a cardiologist at Hennepin County Medical Center (HCMC) in Minneapolis and a member of the University of Minnesota faculty for 29 years. He has been a professor of medicine at the University of Minnesota since 2004. He founded the program in interventional cardiology and served as the director of the cardiac catheterization laboratory at HCMC from 1985 to 1991. Dr. Herzog also served as the director of the cardiac ultrasound laboratory at HCMC from 1997 through 2012. He participated in the development of the National Kidney Foundation’s K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients and the workgroup for the KDIGO Clinical Practice Guidelines on Acute Kidney Injury, and co-chaired the 2010 KDIGO Controversies Conference, "Cardiovascular Disease in CKD: What is it and What Can We Do About It?"
Dr. Herzog is a member of the Executive Committee for the EVOLVE (Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events) Trial, and is Co-PI of the planned WED HED (Wearable External Defibrillator in Hemodialysis) Trial. The author or co-author of more than 150 published papers and reviews, Dr. Herzog has served on the Editorial Board for the American Heart Journal since 2005 and was liaison editor (cardiology) for Nephrology Dialysis Transplantation from 2007 to 2011. Areas of research and special interests include cardiac disease and chronic kidney disease, and echocardiography.
University of Rochester, Rochester, NY, USA
Internal Medicine, University of Minnesota, Minneapolis, MN, USA
Cardiology, University of Minnesota, Minneapolis, MN, USA